Cancer Prevention and Health Promotion (CPHP)

Areas Reviewed

Developing and testing strategies to address modifiable risks (such as healthy eating, active living, exercise, alcohol intake, smoking cessation, sunscreen use, and uptake of cancer-preventing vaccines) for cancer prevention and mitigation of outcomes in cancer survivors
Developing and testing cancer prevention interventions that involve cultural tailoring, health literacy, social support, patient-provider communication, shared decision-making, and social marketing
Mindfulness-based interventions for general well-being, smoking cessation, alcohol reduction, weight loss, and other healthy behaviors
Dissemination and implementation science research to promote evidence-based practices, interventions, and policies across the cancer control continuum
Understanding and removing barriers to participation in research studies and clinical trials

Co-Chair, Christina M. Dieli-Conwright, PhD, MPH, Harvard Medical School

Co-Chair, Maija Reblin, MA, PhD, University of Vermont Cancer Center

Travis Baggett, MD, MPH, Harvard Medical School

Jessica R. Gorman, MPH, PhD, Oregon State University

Daniel Hall, PhD, MGH Department of Psychiatry, Harvard University

Sandra Japuntich, PhD, LP, University of Minnesota Medical School, Hennepin Healthcare Research Institute

Anne E. Kazak, MA, PhD, Nemours Center for Healthcare Delivery Science

Kimberly M. Kelly, PhD, MS, FSBM, The University of Tennessee Health Science Center

Jennifer W. Mack, MD, Harvard Medical School

Yamilé Molina, MS, MPH, PhD, University of Illinois Chicago

Harvey J. Murff, MD, MPH, Vanderbilt University Medical Center

Sarah Prinsloo, PhD, MD Anderson Cancer Center

Jessica Scott, PhD, Memorial Sloan Kettering Cancer Center

Carmina Valle, PhD, MPH, University of North Carolina at Chapel Hill

Christina Wang, MD, Icahn School of Medicine at Mount Sinai

Joseph Winger, PhD, Duke University